Invesco’s Transphorm, Inc. Common Stock TGAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-10,118
Closed -$36.9K 3962
2023
Q4
$36.9K Sell
10,118
-1,796
-15% -$4.92K ﹤0.01% 3777
2023
Q3
$26.4K Hold
11,914
﹤0.01% 3845
2023
Q2
$40.5K Buy
11,914
+1,198
+11% +$4.32K ﹤0.01% 3830
2023
Q1
$42.8K Buy
10,716
+395
+4% +$1.74K ﹤0.01% 3767
2022
Q4
$56.1K Sell
10,321
-881
-8% -$5.18K ﹤0.01% 3903
2022
Q3
$56K Sell
11,202
-4,134
-27% -$20.4K ﹤0.01% 3908
2022
Q2
$59K Buy
+15,336
New +$97.9K ﹤0.01% 3955

Other funds holding TGAN

Invesco's TGAN Position: Q1 2024 in Review

Invesco sold out of Transphorm, Inc. Common Stock (TGAN) in Q1 2024, closing a stake of 10,118 shares — an estimated $36.9K sold.

Invesco first reported a position in TGAN in Q2 2022 and held it in 7 quarters. The position peaked at $59K in Q2 2022. 57 funds tracked by Wall St. Rank hold TGAN as of Q1 2024.

  • Invesco reported no remaining Transphorm, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Invesco sold 10,118 Transphorm, Inc. Common Stock shares in Q1 2024, an estimated $36.9K.
  • Invesco first reported a position in Transphorm, Inc. Common Stock in Q2 2022 and held it in 7 quarters.
  • Invesco's Transphorm, Inc. Common Stock position peaked at $59K in Q2 2022.
  • 57 funds tracked by Wall St. Rank held Transphorm, Inc. Common Stock as of Q1 2024.

Based on Invesco's 13F filing for Q1 2024, filed 14 May 2024.